当前位置:首页 - 行情中心 - 益丰药房(603939) - 财务分析 - 现金流量表

益丰药房

(603939)

  

流通市值:430.26亿  总市值:431.32亿
流通股本:10.08亿   总股本:10.11亿

现金流量表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金17,086,865,715.811,668,314,845.956,057,324,064.6620,516,702,909.97
收到其他与经营活动有关的现金471,172,626.76412,739,303.16117,057,559.2159,890,326.7
经营活动现金流入的平衡项目0000
经营活动现金流入小计17,558,038,342.5612,081,054,149.116,174,381,623.8620,676,593,236.67
购买商品、接受劳务支付的现金9,887,147,555.097,516,265,309.243,208,847,110.9811,459,225,603.79
支付给职工以及为职工支付的现金3,079,364,056.972,062,634,400.32955,896,546.563,089,512,042.29
支付的各项税费875,395,165.48592,123,836.66283,682,696.441,053,051,300.43
支付其他与经营活动有关的现金834,239,705.77502,297,838.41437,109,105.451,154,536,986.01
经营活动现金流出的平衡项目0000
经营活动现金流出小计14,676,146,483.3110,673,321,384.634,885,535,459.4316,756,325,932.52
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额2,881,891,859.251,407,732,764.481,288,846,164.433,920,267,304.15
二、投资活动产生的现金流量:
取得投资收益收到的现金17,084,00017,084,000--
处置固定资产、无形资产和其他长期资产收回的现金净额163,654.95112,412.2357,040.439,027,812.92
收到的其他与投资活动有关的现金2,478,060,739.21,823,086,219.2267,504,449.5719,096,406.63
投资活动现金流入的平衡项目0000
投资活动现金流入小计2,495,308,394.151,840,282,631.4567,561,489.93728,124,219.55
购建固定资产、无形资产和其他长期资产支付的现金263,538,036.15173,157,645.2761,294,271.06587,505,758.95
投资支付的现金53,621,041.9553,621,041.9553,621,041.95350,048,545.4
取得子公司及其他营业单位支付的现金364,209,106.14257,448,478.67115,226,000450,556,053.7
支付其他与投资活动有关的现金3,565,300,0002,696,350,0001,151,000,000614,015,070
投资活动现金流出的平衡项目0000
投资活动现金流出小计4,246,668,184.243,180,577,165.891,381,141,313.012,002,125,428.05
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-1,751,359,790.09-1,340,294,534.44-1,313,579,823.08-1,274,001,208.5
三、筹资活动产生的现金流量:
吸收投资收到的现金14,501,228.53,600,000-77,410,952
其中:子公司吸收少数股东投资收到的现金7,750,0003,600,000--
取得借款收到的现金---80,000,000
筹资活动现金流入平衡项目00-0
筹资活动现金流入小计14,501,228.53,600,000-157,410,952
偿还债务支付的现金81,359,893.41,000,000-131,693,919.8
分配股利、利润或偿付利息支付的现金373,767,927.83165,408,965.63,792,172.15316,214,007.36
其中:子公司支付给少数股东的股利、利润72,744,679.5718,045,067.09-81,195,720.31
支付其他与筹资活动有关的现金1,100,069,023.79722,025,542.19337,733,625.431,364,769,958.6
筹资活动现金流出平衡项目0000
筹资活动现金流出小计1,555,196,845.02888,434,507.79341,525,797.581,812,677,885.76
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-1,540,695,616.52-884,834,507.79-341,525,797.58-1,655,266,933.76
现金及现金等价物净增加额平衡项目000-0.01
五、现金及现金等价物净增加额-410,163,547.36-817,396,277.75-366,259,456.23990,999,161.88
加:期初现金及现金等价物余额2,918,199,648.452,918,199,648.452,918,199,648.451,927,200,486.57
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额2,508,036,101.092,100,803,370.72,551,940,192.222,918,199,648.45
补充资料:
净利润-798,862,057.68-1,427,194,872.37
资产减值准备-34,609,009.5-56,018,740.98
固定资产和投资性房地产折旧-79,578,407.14-159,652,438.4
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-79,578,407.14-159,652,438.4
无形资产摊销-15,242,851.64-27,324,571.55
长期待摊费用摊销-99,919,618.66-145,378,461.51
处置固定资产、无形资产和其他长期资产的损失--15,378,661.1--23,167,141.5
固定资产报废损失-977,181.21-10,330,017.64
财务费用-79,896,398.07-165,208,532.62
投资损失--29,825,708.67--6,868,722.97
递延所得税-41,086,302.12-4,283,046.2
其中:递延所得税资产减少--3,411,812.41--17,264,551.56
递延所得税负债增加-44,498,114.53-21,547,597.76
存货的减少--42,875,843.26--459,394,401.53
经营性应收项目的减少-385,105,518.07--1,013,307,787.54
经营性应付项目的增加--722,219,480.24-2,139,864,914.12
其他-27,478,666-23,159,834
现金的期末余额-2,100,803,370.7-2,918,199,648.45
减:现金的期初余额-2,918,199,648.45-1,927,200,486.57
公告日期2023-10-312023-08-302023-04-282023-04-28
审计意见(境内)标准无保留意见
TOP↑